Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

XRPH partners with Molecular Science Signals creating a natural high for Crypto market, backed by USD Millions in research

This image opens in the lightbox

News provided by

XRP Healthcare

04 Apr, 2023, 07:30 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, April 4, 2023 /PRNewswire/ -- XRP Healthcare has announced yet another partnership, with Signals, a forward-thinking company that leverages molecular information - Resonant Molecular Signaling (RMS) - to develop products that encourage our bodies to naturally return to a state of well-being. Since its inception in 2019, Signals has harnessed over forty years and millions of dollars of research and clinical studies to create an infused tablet with specific energy signals that restore communication within and between cells to promote wellness and bring the human body back into a state of homeostasis.

Continue Reading
This image opens in the lightbox
XRPH partners with Molecular Science Signals creating a natural high for Crypto market, backed by USD Millions in research

The pioneering organization has partnered with XRP Healthcare to develop a range of products utilizing molecular information to encourage natural wellness. This collaboration will bring progressive technology to the market - Signal's products will be available on XRP Healthcare's decentralized marketplace, fueled by the XRPH token, and provide an affordable drug-free solution for maintaining optimal health.

One of the first products being brought to market fueled by XRPH and powered by Signals is CCC+C which stands for Cool, Calm, Collected + Crypto and is based on Resonant Molecular Signaling. Cool, Calm, Collected + Crypto combines a low dose of specific molecules to stimulate the body's natural healing processes and restore balance. This innovative approach provides individuals with a safe, natural way to ease feelings of apprehension, nervousness, and melancholy and is specifically designed to help individuals manage anxiety and stress levels effectively.

CCC+C along with other innovative non-traditional and traditional medication will be available to purchase on XRP Healthcare's online platform using their native token XRPH later this quarter.

The partnership between XRP Healthcare and Signals represents a significant milestone in the field of health, as the two organizations will work together to bring innovative solutions to the market. With Signals' unique approach to wellness and XRP Healthcare's commitment to making healthcare accessible for all patients, the partnership holds the promise of transforming the industry and helping bring well-being to individuals everywhere.

Brian J Esposito, Head of Global Strategy at XRP Healthcare, emphasized the importance of mental wellness in today's turbulent world. He sees Signals' products as a powerful tool to reduce anxiety and stress and help individuals achieve a state of calm and mental well-being:

"First order of business at XRP Healthcare and the crypto world is to help everyone reduce their anxiety and stresses in this exciting and turbulent world. In order to succeed in any industry and life, is to be cool calm and collected which is why we partnered with signals - from here we can all work together, grow, and succeed from a strong place of mental health and wellness."

Kain Roomes, Founder of XRP Healthcare, praised Signals for their extensive research and funding, noting that the partnership with such a trailblazing organization aligns with XRP Healthcare's mission to provide exceptional healthcare solutions:

"Having been an investor in the cryptocurrency space and now starting a healthcare company on the XRP Ledger, I know first-hand about the tumultuous crypto market — having taken CCC myself, it has enabled me to remain cool calm, and collected in a highly volatile, and fickle space. The amount of research and funding that has gone into this product is phenomenal — we're delighted to partner with such a trailblazing company."

XRP Healthcare's Business Development manager Laban Roomes said:

"I take CCC+C when I need to relax, while at the same time maintaining the ability to be highly focused – naturally. In the role I occupy at XRP Healthcare, it is imperative to remain calm, while alert and focused, especially in the volatile crypto space where critical thinking and decision-making can be the difference between failure and success."

Rob Bengston, President of Signals, has also expressed his enthusiasm for the partnership, stating that XRP Healthcare's platform offers an ideal opportunity to make Signals' products readily available to everyone:

"We are excited and enthusiastic to partner with XRP Healthcare and bring our cutting-edge technology to the marketplace"

Meanwhile, Margaret Nies, Signals' Vice President, envisions a future where their products are easily accessible to all, making this partnership a significant step towards achieving that goal:

"Our vision is to have Signals products readily available to all, and partnering with XRP Healthcare is a step to making this a reality."

In today's fast-paced and stressful world, it is easy to get lost in the daily hustle and forget about well-being and mental health.  Mental health disorders, such as depression, anxiety, and substance abuse, are prevalent in today's society and can have severe consequences if left untreated. Prioritizing well-being and mental health reaps numerous benefits that enhance the quality of life.

Photo: https://mma.prnewswire.com/media/2046644/XRPH_partners_with_Molecular_Science.jpg
Logo: https://mma.prnewswire.com/media/1983109/XRP_Healthcare_Logo.jpg

Modal title

Also from this source

XRP Healthcare to Become Public Company via IPO by Q3 2025, Accelerating AI and M&A Expansion

XRP Healthcare to Become Public Company via IPO by Q3 2025, Accelerating AI and M&A Expansion

XRP Healthcare, a fast-growing innovator in AI-driven healthcare and mergers & acquisitions, has announced it will be a public company by Q3 2025....

XRP Healthcare Acquires Pharma Ville, a Retail and Wholesale Pharmacy Chain in Uganda

XRP Healthcare Acquires Pharma Ville, a Retail and Wholesale Pharmacy Chain in Uganda

XRP Healthcare, a pioneering force in healthcare innovation, has officially acquired Pharma Ville, a leading retail and wholesale pharmacy chain in...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Mental Health

Mental Health

Computer & Electronics

Computer & Electronics

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.